Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001623632-25-001475
Filing Date
2025-10-28
Accepted
2025-10-28 16:39:46
Documents
6

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 20515
2 ANNEX A CLASSIFICATION OF REPORTING PERSONS annexa.htm EX-99 11374
3 EXHIBIT 1 AGREEMENT FOR JOINT FILING exhibit1.htm EX-99 8775
4 POWER OF ATTORNEY powerofattorneytrd.htm EX-99 4011
5 POWER OF ATTORNEY powerofattorneyacd.htm EX-99 3971
6 EXHIBIT 2 SUPPORT AGREEMENT exhibit2supportagreement.htm EX-99 16326
  Complete submission text file 0001623632-25-001475.txt   66980
Mailing Address 1001 LIBERTY AVENUE PITTSBURGH PA 15222
Business Address 1001 LIBERTY AVENUE PITTSBURGH PA 15222 4122881900
FEDERATED HERMES, INC. (Filed by) CIK: 0001056288 (see all company filings)

EIN.: 251111467 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SCHEDULE 13D
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 1500 DISTRICT AVENUE BURLINGTON MA 01803
Business Address 1500 DISTRICT AVENUE BURLINGTON MA 01803 617-600-7373
Minerva Neurosciences, Inc. (Subject) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-88240 | Film No.: 251425442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)